UBS AM’s Starling Oncology STLN Stock Holding History
Bought
Maintained
Sold
Other funds holding STLN
JAIC
UBS AM's STLN Position: Q3 2026 in Review
UBS AM reported 1,265 shares of Starling Oncology (STLN) worth $8K in Q3 2026. The position accounts for ﹤0.01% of the portfolio, ranked #3840.
131 funds tracked by Wall St. Rank hold STLN as of Q3 2026.
- UBS AM held 1,265 shares of Starling Oncology worth $8K as of Q3 2026.
- Starling Oncology made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #3840 holding.
- 131 funds tracked by Wall St. Rank held Starling Oncology as of Q3 2026.
Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.